Method for producing an active ingredient concentrate, and an active ingredient concentrate
OwnerDariush Behnaminventor
Life of this patent
Estimating the term…
Abstract
A method is described for the production of a water-soluble phase of an active substance, which is insoluble or only soluble with difficulty in water and is physiologically effective, the active substance, while heated, being stirred with an excess of a physiologically compatible solubiliser with an HLB value between 9 and 16 for the formation of a transparent intermediate product, the said intermediate product being cooled to room temperature. Also, a water-soluble concentrate of a physiologically active substance is described.
Claims23
Method for the production of a water-soluble phase of an active substance, which is insoluble or only soluble with difficulty in water and is physiologically effective, characterised in that the active substance is, while heated, stirred with an excess of a physiologically compatible solubiliser with an HLB value between 9 and 16 for the formation of a transparent intermediate product and the intermediate product is cooled to room temperature.
Method according to one of the previous claims, characterised in that an auxiliary substance, for example linoleic acid, is added while heated to the mixture of active substance and solubiliser.
Method according to one of the previous claims, characterised in that the solubiliser is added in such an excess that the intermediate product comprises an active substance concentration of approximately 20% or less.
Method according to one of the previous claims, characterised in that the solubiliser is heated to a temperature of about 80° C. to about 100° C.
Method according to one of the previous claims, characterised in that the intermediate product is cooled quickly.
Method according to one of the previous claims, characterised in that the coenzyme Q10 is used as the active substance.
Water-soluble concentrate of a physiological active substance, insoluble or only soluble with difficulty in water, which comprises an excess of a physiologically compatible solubiliser with an HLB value of 9 to 16.
Dependencies are inferred from the claim text.